Literature DB >> 24704503

Clinical and radiographic degenerative spondylolisthesis (CARDS) classification.

Christopher K Kepler1, Alan S Hilibrand2, Amir Sayadipour2, John D Koerner2, Jeffrey A Rihn2, Kristen E Radcliff2, Alexander R Vaccaro2, Todd J Albert2, D Greg Anderson2.   

Abstract

BACKGROUND CONTEXT: Lumbar degenerative spondylolisthesis (DS) is a common, acquired condition leading to disabling back and/or leg pain. Although surgery is common used to treat patients with severe symptoms, there are no universally accepted treatment guidelines. Wide variation in vertebral translation, disc collapse, sagittal alignment, and vertebral mobility suggests this is a heterogeneous disease. A classification scheme would be useful to differentiate homogenous subgroups that may benefit from different treatment strategies.
PURPOSE: To develop and test the reliability of a simple, clinically useful classification scheme for lumbar DS. STUDY
DESIGN: Retrospective case series. PATIENT SAMPLE: One hundred twenty-six patients. OUTCOME MEASURES: Proposed radiographic classification system.
METHODS: A classification system is proposed that considers disc space height, sagittal alignment and translation, and the absence or presence of unilateral or bilateral leg pain. Test cases were graded by six observers to establish interobserver reliability and regraded in a different order 1 month later to establish intraobserver reliability using Kappa analysis. To establish the relative prevalence of each subtype, a series of 100 consecutive patients presenting with L4-L5 DS were classified.
RESULTS: Four radiographic subtypes were identified: Type A: advanced Disc space collapse without kyphosis; Type B: disc partially preserved with translation of 5 mm or less; Type C: disc partially preserved with translation of more than 5 mm; and Type D: kyphotic alignment. The leg pain modifier 0 denotes no leg pain, 1 denotes unilateral leg pain, and 2 represents bilateral leg pain. The Kappa value describing interobserver reliability was 0.82, representing near-perfect agreement. Intraobserver reliability analysis demonstrated Kappa=0.83, representing near-perfect agreement. Grading of the consecutive series of 100 patients revealed the following distribution: 16% Type A, 37% Type B, 33% Type C, and 14% Type D.
CONCLUSIONS: A new radiographic and clinical classification scheme for lumbar DS with high inter- and intraobserver reliabilites is proposed. Use of this classification scheme should facilitate communication to enhance the quality of outcomes research on DS.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Classification system; Degenerative spondylolisthesis; Iatrogenic destabilization; Lumbar degenerative spondylolisthesis; Lumbar spinal fusion; Spondylolisthesis

Mesh:

Year:  2014        PMID: 24704503     DOI: 10.1016/j.spinee.2014.03.045

Source DB:  PubMed          Journal:  Spine J        ISSN: 1529-9430            Impact factor:   4.166


  10 in total

1.  Description of the sagittal alignment of the degenerative human spine.

Authors:  Amer Sebaaly; Pierre Grobost; Lisa Mallam; Pierre Roussouly
Journal:  Eur Spine J       Date:  2017-11-24       Impact factor: 3.134

2.  A new classification system for degenerative spondylolisthesis of the lumbar spine.

Authors:  Olivier Gille; Houssam Bouloussa; Simon Mazas; Claudio Vergari; Vincent Challier; Jean-Marc Vital; Pierre Coudert; Soufiane Ghailane
Journal:  Eur Spine J       Date:  2017-08-23       Impact factor: 3.134

3.  Does change in focal lordosis after spinal fusion affect clinical outcomes in degenerative spondylolisthesis?

Authors:  Brian A Karamian; Stephen DiMaria; Mark J Lambrechts; Nicholas D D'Antonio; Andrew Sawires; Jose A Canseco; I David Kaye; Barrett I Woods; Mark F Kurd; Jeffery A Rihn; Joseph K Lee; Alan S Hilibrand; Christopher K Kepler; Alexander R Vaccaro; Gregory D Schroeder
Journal:  J Craniovertebr Junction Spine       Date:  2022-06-13

4.  How does spinopelvic alignment influence short-term clinical outcomes after lumbar fusion in patients with single-level degenerative spondylolisthesis?

Authors:  Stephen DiMaria; Brian A Karamian; Mark J Lambrechts; Arun P Kanhere; John J Mangan; Winston W Yen; Arlene Maheu; Mahir A Qureshi; Jose A Canseco; David I Kaye; Barrett I Woods; Mark F Kurd; Kris E Radcliff; Alan S Hilibrand; Christopher K Kepler; Alexander R Vaccaro; Gregory D Schroeder
Journal:  J Craniovertebr Junction Spine       Date:  2022-09-14

5.  Defining Instability in Degenerative Spondylolisthesis: Surgeon Views.

Authors:  Nicholas Spina; Carlijn Schoutens; Brook I Martin; Darrel S Brodke; Brandon Lawrence; William Ryan Spiker
Journal:  Clin Spine Surg       Date:  2019-12       Impact factor: 1.876

Review 6.  Current Status of Lumbar Interbody Fusion for Degenerative Spondylolisthesis.

Authors:  Toshiyuki Takahashi; Junya Hanakita; Yasufumi Ohtake; Yusuke Funakoshi; Yuki Oichi; Taigo Kawaoka; Mizuki Watanabe
Journal:  Neurol Med Chir (Tokyo)       Date:  2016-05-11       Impact factor: 1.742

7.  Management of symptomatic degenerative low-grade lumbar spondylolisthesis.

Authors:  Nick Evans; Michael McCarthy
Journal:  EFORT Open Rev       Date:  2018-12-19

8.  Clinical, Functional, and Radiologic Outcome of Single- and Double-Level Transforaminal Lumbar Interbody Fusion in Patients with Low-Grade Spondylolisthesis.

Authors:  Keyvan Eghbal; Babak Pourabbas; Hamid Reza Abdollahpour; Reza Mousavi
Journal:  Asian J Neurosurg       Date:  2019 Jan-Mar

9.  Comparison of the French and CARDS classifications for lumbar degenerative spondylolisthesis: reliability and validity.

Authors:  Chao Kong; Xiangyao Sun; Junzhe Ding; Machao Guo; Xiangyu Li; Shibao Lu
Journal:  BMC Musculoskelet Disord       Date:  2019-08-20       Impact factor: 2.362

10.  Comparison of SDSG and CARDS classifications for L5/S1 lumbar degenerative spondylolisthesis: an independent inter- and intra-observer agreement study.

Authors:  Zhengwang Sun; Chongqing Xu; Mengchen Yin; Wangjun Yan
Journal:  J Orthop Surg Res       Date:  2021-06-15       Impact factor: 2.359

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.